Tang discusses the limitations in available data, but nonetheless high potential, of SBRT in kidney cancer. As Tang noted in his ASTRO 2024 presentation topic, SBRT has been linked to significantly ...

F-flotufolastat shows a 69% detection rate for recurrent prostate cancer in patients with PSA levels above 0.2 ng/mL post-prostatectomy. The agent demonstrates a 50% detection rate for PSAs below 0.2 ...

Talazoparib plus enzalutamide significantly improved overall survival in mCRPC patients, including those with HRR gene mutations. The treatment's safety profile aligns with known data for talazoparib ...

"If the documentation supported the use of modifier –22, it should be appended," write Jonathan Rubenstein, MD, and Mark Painter. As with most cases, we need to start with a review of the ...

SunRISe-4 targets MIBC patients ineligible for or refusing cisplatin-based chemotherapy, addressing an unmet medical need. The trial evaluates TAR-200 plus cetrelimab and cetrelimab monotherapy, ...

Aquablation with HYDROS is a transurethral water jet procedure for BPH, combining resective and non-resective therapy benefits. The HYDROS system uses AI-powered treatment planning and real-time ...

The study evaluates Focal One robotic HIFU for BPH, focusing on safety and efficacy in a phase 1/2 trial. Phase 1 determines optimal treatment parameters, while phase 2 expands enrollment to assess ...

"We remain on track for the opening of phase 2 in the next few months. We also expect to see the full phase 1 results presented at a scientific meeting in 2025," says David E. Gauden, DPhil. Lutetium ...

Androgen deprivation therapy significantly increases depression risk in prostate cancer patients, with a 60% higher incidence rate. White patients on androgen deprivation therapy are more likely to be ...

ART post-RC in MIBC patients shows no significant increase in acute or late toxicity, with mild bowel toxicity being more frequent. Historical concerns about bowel exposure have limited ART use, but ...

Aquablation offers a versatile treatment for BPH, accommodating various prostate sizes and shapes, with a relatively flat learning curve for urologists. Proper patient selection is crucial for ...

Elevated baseline CTC count in mHSPC patients is linked to poor PSA response, rapid progression, and decreased overall survival. The study analyzed 1313 samples, finding that 11.9% had 5 or more CTCs ...